Literature DB >> 29464861

Glioma infiltration and extracellular matrix: key players and modulators.

Valéria Pereira Ferrer1, Vivaldo Moura Neto1, Rolf Mentlein2.   

Abstract

An outstanding characteristic of gliomas is their infiltration into brain parenchyma, a property that impairs complete surgical resection; consequently, these tumors might recur, resulting in a high mortality rate. Gliomas invade along preferential routes, such as those along white matter tracts and in the perineuronal and perivascular spaces. Brain extracellular components and their partners and modulators play a crucial role in glioma cell invasion. This review presents an extensive survey of the literature, showing how the brain extracellular matrix (ECM) is modulated during the glioma infiltration process. We explore aspects of ECM interaction with glioma cells, reviewing the main glycosaminoglycans, glycoproteins and proteoglycans. We discuss the roles of ECM-binding proteins, including CD44, RHAMM, integrins and axonal guidance molecules, and highlight the role of proteases and glycosidases in glioma infiltration; in binding and release chemokines, cytokines and growth factors; and in generating new bioactive ECM fragments. We also consider the roles of cytoskeletal signaling, angiogenesis, miRNAs and the glial-to-mesenchymal transition linked to glioma invasion. We closely discuss therapeutic approaches based on the modulation of the extracellular matrix, targeting the control of glioma infiltration, its relative failure in clinical trials, and potential means to overcome this difficulty.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  extracellular matrix; glioma; glycosidases; infiltration; proteases

Mesh:

Year:  2018        PMID: 29464861     DOI: 10.1002/glia.23309

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  40 in total

1.  PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.

Authors:  Chengyuan Dong; Wenhua Fan; Sheng Fang
Journal:  J Mol Neurosci       Date:  2019-10-15       Impact factor: 3.444

2.  Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization.

Authors:  Cornelia Tolg; Muhan Liu; Katelyn Cousteils; Patrick Telmer; Khandakar Alam; Jenny Ma; Leslie Mendina; James B McCarthy; Vincent L Morris; Eva A Turley
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

3.  Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.

Authors:  Jiping Wang; Jianmei W Leavenworth; Anita B Hjelmeland; Reed Smith; Neha Patel; Ben Borg; Ying Si; Peter H King
Journal:  Glia       Date:  2019-08-10       Impact factor: 7.452

4.  Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients.

Authors:  Guilong Tanzhu; Na Li; Zhanzhan Li; Rongrong Zhou; Liangfang Shen
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

Review 5.  The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.

Authors:  Rui Sun; Albert H Kim
Journal:  Cancer Metastasis Rev       Date:  2022-08-03       Impact factor: 9.237

6.  Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma.

Authors:  Wen Yin; Hecheng Zhu; Jun Tan; Zhaoqi Xin; Quanwei Zhou; Yudong Cao; Zhaoping Wu; Lei Wang; Ming Zhao; Xingjun Jiang; Caiping Ren; Guihua Tang
Journal:  Cancer Cell Int       Date:  2021-05-25       Impact factor: 5.722

7.  Dichotomy in Growth and Invasion from Low- to High-Grade Glioma Cellular Variants.

Authors:  Krishnendu Ghosh; Samarendranath Ghosh; Uttara Chatterjee; Pritha Bhattacharjee; Anirban Ghosh
Journal:  Cell Mol Neurobiol       Date:  2021-05-12       Impact factor: 4.231

Review 8.  Targeting Glioblastoma Tumor Microenvironment.

Authors:  Megan Butler; Sahdeo Prasad; Sanjay K Srivastava
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  In Vitro Glioblastoma Models: A Journey into the Third Dimension.

Authors:  Mayra Paolillo; Sergio Comincini; Sergio Schinelli
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.

Authors:  Jianjie Zhu; Tingting Cai; Jieqi Zhou; Wenwen Du; Yuanyuan Zeng; Ting Liu; Yulong Fu; Yue Li; Qian Qian; Xiuwei H Yang; Qinglin Li; Jian-An Huang; Zeyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.